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Sir—We have read with great interest the com-
ments of Drs. Eskelinen, Remes and Paavolainen 
on our Letter to the Editor. 
Certainly, we agree with our colleagues that the 
reports by Capello et al. (2003), McLaughlin and 
Lee (2000), Aldinger et al. (2003) and Jacobsen 
et al. (2003) contain important information about 
uncemented hips. However, the authors agree with 
us that none of these reports have fulﬁlled the NICE 
criteria as was originally suggested in their paper.
We can accept the claim of the authors that the 
report by Kim et al. (2003) meets the NICE cri-
teria; we already wrote in our previous letter that 
this paper approaches the minimum survival of 10 
years, so we have no problem in accepting this as a 
paper on uncemented hips that meets the NICE cri-
teria. Although there was no aseptic loosening of 
the components and a relatively low prevalence of 
osteolysis, the authors reported a high rate of linear 
wear of the polyethylene liner almost 10 years after 
surgery. It remains unclear if more revisions for 
this problem are pending in the coming years.
It was indeed remarkable that the report of 
McAuley et al. (2004) was not referred to in the 
original manuscript. Certainly, this report claims a 
survival rate of the THR of 89% at 10 years, with 
any reason as endpoint. Indeed, if liner exchange is 
excluded, the 10-year survival of this uncemented 
THR is 95%. However, does this remark mean that 
the Finnish hip register does not consider a re-
operation for liner exchange to be a hip revision, 
as is done in the Swedish and Norwegian hip reg-
isters? The report of McAuley et al. is also very 
important because this report shows us the longest 
published survival of uncemented hips in patients 
less than 50 years. 
In our previous Letter to the Editor, we men-
tioned that all the published reports of cemented 
hip implants that fulﬁll the NICE criteria had been 
omitted from the original paper. We therefore have 
a major problem with the answer of Drs Eskelinen, 
Remes and Paavolainen on this issue, which sug-
gests that only one report on cemented hips is avail-
able which fulﬁlls the NICE criteria (Keener et al. 
2003). Studies from hip registers do have a major 
inﬂuence on orthopedic practice, therefore these 
reports should be of the highest standard, with 
an adequate overview of the literature. Although 
we sincerely believe that they have reported this 
to the best of their knowledge, the truth is some-
what different. We have found at least 8 studies on 
cemented hips in patients younger than 50 years 
and all of them have fulﬁlled the NICE criteria; 
many of them were already published some time 
ago (Boeree and Bannister 1993, Joshi et al. 1993, 
Devitt et al.1997, Emery et al. 1997, Kobayashi 
et al. 1997, Sochart et al. 1997a,b, Keener et al. 
2003).
Long-term survival data in these reports on 
cemented hips (with revision for any reason as 
endpoint) are as follows: 60% after 30 years 
(Keener et al. 2003), 75% after 20 years (Joshi et 
al. 1993), again 75% after 20 years (Devitt et al. 
1997) and 73% at 20 years (Sochart et al. 1997b). 
These long-term survival data of cemented hips 
are clearly superior to the longest report available 
of uncemented hips (McAuley et al. 2004), which 
has a survival rate at 15 years of 60% (endpoint: 
revision for any reason). After 10 years, there was 
a dramatic increase in liner problems and osteol-
ysis. This problem of high wear of the liner was 
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mented hips that meets the NICE criteria (Kim et 
al. 2003).
In general, one should not be too optimistic 
about the survival of total hip implants, cemented 
or uncemented, in young patients. If concepts of 
hip implants inserted in young patients (less than 
50 years old) are compared with the same implants 
in patients older than 70 years, the survival in the 
younger group is always less favorable. This is also 
shown by the data of the Norwegian and Swedish 
hip registers. 
Certainly, one way of improving the outcome 
in younger patients is to choose the right implant. 
However, choosing the best combinations from the 
analyses of the Finnish register does not guaran-
tee that young patients in Finland will indeed have 
the best outcome in future. First, concepts must be 
clinically proven over a period of at least 10 years, 
secondly ideal combinations may be less favor-
able in real clinical practice. In addition, both the 
Norwegian and Swedish hip registers and the study 
by McAuley et al. (2004) show that the results of 
uncemented hips deteriorate between 10 and 15 
years after surgery. So, follow-ups even longer 
than 10 years are needed.
We are not “throwing away the baby with the 
bathwater”, as suggested. We also conclude that 
an uncemented stem with a cemented cup might 
perhaps offer young patients a better outcome. This 
so-called “reverse hybrid”combination is now pop-
ular in Norway. Time will tell us the outcome. 
Indeed, we are looking forward with great inter-
est to the analysis of results of THR designs (and 
combinations) in young patients from the Finnish 
arthroplasty register. 
BW Schreurs and JWM Gardeniers
Department of Orthopaedics 800, Radboud 
University Nijmegen Medical Centre, PB 9101, 
NL-6500 HB Nijmegen, The Netherlands
B.Schreurs@orthop.umcn.nl
Sir—We thank Drs. Schreurs and Gardeniers for 
their interest in our paper.
This topic is certainly important and worth dis-
cussing, so we wish to make the following com-
ments.
First, it might be beneﬁcial to remind the read-
ers of Acta Orthopaedica about the NICE crite-
ria. Using the most recently available evidence of 
clinical effectiveness, the best prostheses (using 
long-term viability as the determinant) demon-
strate a revision rate of 10% or less at 10 years. 
This should be regarded as the current ‘benchmark’ 
in the selection of prostheses for primary total hip 
replacement (NICE 2003). It is certainly regret-
table that so few published studies on the results 
of THA in young patients meet the NICE criteria. 
Studies that do not strictly meet the NICE criteria 
should not be abandoned, however, as they may 
contain important information.
Secondly, we would like to remind our colleagues 
that our study, based on the Finnish Arthroplasty 
Register, was about primary THA in young patients 
with primary osteoarthritis. Outcome of THA may 
be different depending on the pathology of the 
hip joint, especially in young patients (Joshi et al. 
1993, Sochart and Porter 1997a).
Thirdly, we wish to comment on previous reports 
and the NICE criteria. Our honorable colleagues 
cited Kim et al. (2003), who reported a series of 80 
patients (118 hips) with a mean follow-up of 9.8 
years. Although the authors advocated the use of 
a 22-mm diameter femoral head for the increased 
rate of linear wear in their series (the average wear 
rate being 0.12 mm/year), the volumetric wear rate 
was low (on average 47.19 mm3 per year) and, 
consequently, the prevalence of osteolysis was low. 
Kaplan-Meier survivorship analysis, with revision 
as the endpoint for failure, revealed a 99% rate of 
survival of the acetabular and femoral components 
at 10 years. Thus, it seems—at least to us—unjusti-
ﬁed to speculate that revisions on account of wear 
problems can be expected in the future by Kim and 
colleagues.
The important study of McAuley et al. (2004) 
was not cited in our original manuscript. Again, 
we regret that we did not notice this excellent 
paper. Our colleagues asked which re-operations 
were considered to be revisions in the Finnish 
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Material and Methods: “The endpoint for survival 
was deﬁned as revision when either one compo-
nent (including exchange of liner) or the whole 
implant was removed or exchanged” (Eskelinen et 
al. 2005).
In the series of Sochart and Porter (1997a), the 
authors reported the results of cemented THA in 
161 patients (226 hips) under 40 years of age. 54 of 
these patients (66 hips) had primary osteoarthritis 
(OA), which is similar to the situation with the 
patients in our study. For the patients with OA, 
the probability of survival of both of the original 
components at 10 and 25 years was 86% and 52%, 
respectively. In their series, the average amount 
of linear wear was 0.11 mm/year, and for hips 
that had had a revision it was 0.24 mm/year. The 
other paper from Sochart and Porter cited by our 
colleagues deals with cemented THA in patients 
with ankylosing spondylitis (Sochart and Porter 
1997b), the results of which—in our opinion—can 
hardly be directly compared to our study. The 
same authors have also published the long-term 
results of Charnley LFA in patients aged less than 
30 years (Sochart and Porter 1998). In that paper, 
the survival rate of the THR was 89% at 10 years, 
and 65% at 25 years. What is more, in their series, 
there was a mean annual wear rate of 0.09 mm in 
patients with rheumatoid arthritis or ankylosing 
spondylitis, but of 0.24 mm in patients with degen-
erative arthrosis (avascular necrosis, posttraumatic 
or metabolic). 
Regarding the study of Kobayashi et al. (1997), 
the authors did not actually report survival of the 
total hip at 10 years; instead, survival rates of 
acetabular and femoral components were reported 
separately. So, one cannot conclude anything about 
the NICE criteria from the study of Kobayashi and 
colleagues. It is notable that when revision surgery 
performed for any reason was used as the endpoint, 
the survival rate of sockets in the younger patients 
was 98.2% at 10 years and 68% at 16 years. Annual 
wear rates were unfortunately not reported in this 
study. The authors did state, however, that in 8 of 
the 16 sockets that developed radiographic loosen-
ing in the young patients, rapid polyethylene wear 
was detected 5–10 years before socket loosening.
Keener and co-workers (2003) reported a 60% 
survival rate at 30 years for 93 consecutive Charn-
ley THAs. The authors did not, however, report the 
10-year survival rate for these patients—either in 
this paper, or in the previous reports on the same 
cohort (Sullivan et al. 1994, Callaghan et al. 1998). 
Thus, it is very difﬁcult to conclude that the paper 
by Keener and colleagues would fulﬁll the NICE 
criteria. In this series, the average amount of linear 
wear was 0.0928 mm/year, and volumetric wear 
was 104 mm3/year.
Devitt et al. (1997) reported the results of 118 
Charnley arthroplasties in patients aged 50 years 
or younger at the time of surgery. The 10-year sur-
vival rate of these hips was not mentioned in the 
original paper, but inspection of the survival curves 
shows that it was clearly under 90%. What is more, 
patients with primary osteoarthritis showed a 64% 
survival rate at 20 years. Note that acetabular wear 
averaged 0.14 mm/year in these patients. The only 
description of uncemented hips fulﬁlling the NICE 
criteria reported a wear rate of 0.12 mm/year (Kim 
et al. 2003).
The report by Emery and colleagues clearly ful-
ﬁlls the NICE criteria (Emery et al. 1997). Wear 
rates were unfortunately not reported in this paper.
Boeree and Bannister (1993) reported the results 
of 46 cemented THAs in 34 patients. At a mean 
follow-up of 12 years, 6 of the 34 original patients 
had a surviving primary THA, meaning a 90% sur-
vival rate at 10 years for this series. Thus, the NICE 
criteria were fulﬁlled. The authors mentioned in 
the discussion that 6 other stems and 5 cups were 
likely to require revision for aseptic loosening in 
the near future.
Joshi and co-workers published results of 218 
Charnley THAs in 141 patients who were 40 
years old or younger at the time of surgery (Joshi 
et al. 1993). The probability of implant survival 
for these patients was 93% at 10 years and again, 
the NICE criteria were fulﬁlled. For patients with 
osteoarthritis, survival rate of the THA was about 
80% at 10 years (from inspection of the curve; the 
exact rate was not given), and 51% at 20 years. Is it 
really justiﬁed to claim that the results of cemented 
implants do not deteriorate after 10 years? The 
authors concluded that in young patients, cemented 
THA is a good procedure for those with rheumatoid 
arthritis—but that the results are much less reliable 
in those with osteoarthritis. We agree with them.
Schreurs and Gardeniers claimed that the Swed-
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that all implant concepts have poorer results in 
young patients. To the best of our knowledge, this 
kind of information has not been published from 
Nordic registers. Malchau et al. (2002) reported 
from the Swedish Arthroplasty Register that in 
general THRs in younger patients (< 55 years of 
age) show poorer survival than in older patients. 
In that study, the results of using different con-
cepts were not compared between age groups. 
In the cohort of patients who were younger than 
55 years at the time of the index operation, there 
was no signiﬁcant difference between cemented, 
uncemented, and hybrid implants, although there 
was a trend toward superior results for the unce-
mented and hybrid ﬁxation. In a study from the 
Norwegian Arthroplasty Register, Havelin and 
co-workers found that in younger patients (< 60 
years of age), the uncemented circumferentially 
porous or hydroxyapatite- (HA)-coated femoral 
stems had better survival rates than the cemented 
ones (Havelin et al. 2000), which is in accordance 
with our results (Eskelinen et al. 2005). They also 
found that cemented cups had better survival than 
uncemented porous-coated cups, mainly because 
of higher rates of revision from wear and oste-
olysis in the latter. In our material, there was no 
difference between press-ﬁt uncemented and all-
polyethylene cemented cups, when all cup revi-
sions were taken into account (Eskelinen et al. 
2005).
What can we conclude about cemented 
hip implants in young patients with primary 
osteoarthritis? First, there has not been a single 
study about cemented THA in young patients with 
primary osteoarthritis fulﬁlling the NICE criteria. 
To be exact, this is also the case for uncemented 
implants, as the study by Kim et al. (2003) includes 
different hip diseases. Secondly, the results of 
cemented hip implants do deteriorate after 10 years 
of follow-up in younger patients. Thirdly, cemented 
cups do have problems, both with wear and aseptic 
loosening in these patients.
It must be noted that our study was based on the 
Finnish Arthroplasty Register. Most studies from 
single centers have a relatively small number 
of patients, and they often provide readers with 
results involving single surgeons. Register-based 
studies provide us with valuable insight into the 
use of the THA procedure in a certain patient 
group, as the number of arthroplasties under 
study (and surgeons) is usually large. Often, the 
results of a new implant or method are good in a 
single-center study—but can these results be gen-
eralized to the population level? This is a question 
to which only a register-based study may give the 
answer. Even so, we acknowledge that the cur-
rent register-based study had certain limitations. 
We were not, for instance, able to report any sub-
jective outcome measurements, e.g. Harris Hip 
Score or disease-speciﬁc quality of life measure-
ments, or to perform radiographic analysis with 
wear measurements. When studying the results of 
THAs published in the literature, we should eval-
uate those based on registers and those reported 
by single centers from different points of view. 
Results from these different sources complement 
each other. Both types of studies will certainly be 
needed in future evaluations of the results of hip 
implants.
Our Dutch colleagues conclude that one could 
use an uncemented stem with a cemented cup, 
which would provide young patients with better 
outcomes. Whenever the femoral side is con-
cerned, we absolutely agree. Our study has shown 
without a doubt that these young patients beneﬁt 
from a modern uncemented stem (Eskelinen et al. 
2005). The problem is really the acetabular side: 
aseptic loosening with the cemented cups (Eske-
linen et al. 2005), wear and osteolysis with the 
uncemented modular ones (Harris 2003). In our 
opinion, there are three possible solutions: (1) 
the “reverse hybrid” concept discussed by our 
colleagues, (2) uncemented modular cups with 
improved liner congruence and diminished wear 
(and/or uncemented cups with molded polyeth-
ylene to avoid the back-side wear or loosening/
breakage of the liner), and (3) hard-on-hard artic-
ulations, which have been widely used recently by 
orthopedic surgeons in Finland. There is a lack of 
long-term results with these three concepts. Cer-
tainly, only time will tell us the eagerly awaited 
answer.
Again, we thank our honorable colleagues for 
their interest in our paper, and for the fruitful dis-
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